Elementis Pharma
Germany Updated 9 July 2026
Elementis Pharma is a contract manufacturer based in Germany. Its GMP standing is certified by ZLG (DE) and EMA. Its most recent recorded inspection, by US FDA, closed on 6 February 2020 as VAI.
3
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Inspection history
- 6 February 2020 VAI US FDA
- 26 January 2016 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Ludwigshafen Am Rhein, Germany | Not on file |
| Rhineland-Palatinate, Germany | Not on file |
| Germany, Germany | 3002807069 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| ZLG (DE) | None | 6 |
| EMA | None | 2 |
Comparing suppliers?
Choose your molecules and target markets. Elementis Pharma comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 6 February 2020.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates